Safety of Progestogen Hormonal Contraceptive Methods during Lactation: An Overview
- PMID: 38921261
- PMCID: PMC11203090
- DOI: 10.3390/clinpract14030083
Safety of Progestogen Hormonal Contraceptive Methods during Lactation: An Overview
Abstract
Background: Breastfeeding is a process for not only nourishing infants but also for building a unique emotional bond between mother and child. Therefore, the ideal contraception during lactation should not affect lactation (milk composition, milk volume) and offspring development.
Objectives: This study aims to analyze the literature on the safety of progestogen hormonal contraceptive methods during lactation.
Methods: We conducted a thorough search across various databases, including the National Library of Medicine (PubMed), and the Cochrane Database, Drugs and Lactation Database (LactMed). Our search utilized specific phrases such as: "lactation" and "breastfeeding" and "oral contraception" with "drospirenone" or "desogestrel", with "subcutaneous etonogestrel implant" or "etonogestrel implant", with "levonorgestrel-releasing intrauterine system", and "emergency contraception", with "levonorgestrel" or "ulipristal acetate".
Conclusions: Based on published scientific reports, progestogen hormonal contraceptives can be considered a relatively safe solution for women desiring to continue feeding their infant with their milk while using hormonal contraception. It is important to seek guidance on selecting the best contraception method based on the latest medical knowledge, tailored to the individual needs and clinical circumstances of each woman and place of residence. A woman should always be informed of the potential risks of such a treatment and then allowed to make her own decision based on the knowledge received from a specialist.
Keywords: breastfeeding; contraception; lactation.
Conflict of interest statement
The author K.C.-W. cooperated with EXELTIS on the sponsored manuscript: Begier-Krasińska, B.; Krasiński, Z.; Rzymski, P.; Sajdak, S.; Chmaj-Wierzchowska, K.; Zawiejska, A. Opinia na temat bezpieczeństwa, skuteczności i wskazań do stosowania jenoskładnikowej antykoncepcji w postaci 4 mg drospirenonu. Ginekologia po Dyplomie. Styczeń 2024 [in Polish] and declare no relevant conflicts of interest. EXELTIS does not participate in the design, execution, interpretation or writing of the study. The remaining authors declare no conflicts of interest.
Similar articles
-
Canadian Contraception Consensus (Part 2 of 4).J Obstet Gynaecol Can. 2015 Nov;37(11):1033-9. doi: 10.1016/s1701-2163(16)30054-8. J Obstet Gynaecol Can. 2015. PMID: 26629725 English, French.
-
Canadian Contraception Consensus (Part 1 of 4).J Obstet Gynaecol Can. 2015 Oct;37(10):936-42. doi: 10.1016/s1701-2163(16)30033-0. J Obstet Gynaecol Can. 2015. PMID: 26606712 English, French.
-
A review of the use of progestogen-only minipills for contraception during lactation.Reprod Fertil Dev. 1991;3(3):245-54. doi: 10.1071/rd9910245. Reprod Fertil Dev. 1991. PMID: 1947224 Review.
-
Hormonal contraception and lactation.J Hum Lact. 1996 Dec;12(4):315-8. doi: 10.1177/089033449601200419. J Hum Lact. 1996. PMID: 9025449 Review.
-
[Contraceptive methods used by women in the period before and after giving birth].Ceska Gynekol. 2009 Jun;74(3):211-8. Ceska Gynekol. 2009. PMID: 19642521 Czech.
References
-
- Diplock A.T., Aggett P.J., Ashwell M., Bornet F., Fern E.B., Roberfroid M.B. Scientific Concepts of Functional Foods in Europe: Consensus document. Br. J. Nutr. 1999;81:1. - PubMed
-
- World Health Organization. United Nations Children’s Fund . Global Strategy for Infant and Young Child Feeding. World Health Organization; Geneva, Switzerland: 2003.
-
- Johnston M., Landers S., Noble L., Szucs K., Viehmann L. Breastfeeding and the use of human milk. Pediatrics. 2012;129:e827–e841. - PubMed
Publication types
LinkOut - more resources
Full Text Sources